Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
TB-500: Evidence Summary
Evidence summary for TB-500 across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to TB-500 overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Wound healing | Tier C | 8 | Strong preclinical, limited human clinical data |
| Musculoskeletal recovery | Tier C | 5 | Animal models show accelerated recovery |
| Cardiac repair | Tier D | 2 | Promising preclinical, no human RCTs |